SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Inspiration Biopharmaceuticals Announces Filing of Biologics License Application (BLA) for IB1001, a Recombinant Factor IX Product for People with Hemophilia B
Your Message